In vitro susceptibilities of clinical yeast isolates to a new echinocandin derivative, LY303366, and other antifungal agents.
about
Effectiveness of anidulafungin in eradicating Candida species in invasive candidiasis.In vitro activities of anidulafungin against more than 2,500 clinical isolates of Candida spp., including 315 isolates resistant to fluconazolePharmacokinetics and pharmacodynamics of antifungals in children: clinical implicationsIn vitro activity of A-192411.29, a novel antifungal lipopeptideEfficacy of FK463, a (1,3)-beta-D-glucan synthase inhibitor, in disseminated azole-resistant candida albicans infection in miceIn vitro susceptibility testing methods for caspofungin against Aspergillus and Fusarium isolatesComparison of In vitro activities of the new triazole SCH56592 and the echinocandins MK-0991 (L-743,872) and LY303366 against opportunistic filamentous and dimorphic fungi and yeastsIn vitro activity of the echinocandin antifungal agent LY303,366 in comparison with itraconazole and amphotericin B against Aspergillus spp.Antifungal efficacy, safety, and single-dose pharmacokinetics of LY303366, a novel echinocandin B, in experimental pulmonary aspergillosis in persistently neutropenic rabbits.Antifungal peptides: novel therapeutic compounds against emerging pathogensComparison of the in vitro activities of the echinocandin LY303366, the pneumocandin MK-0991, and fluconazole against Candida species and Cryptococcus neoformansEfficacy of LY303366 against amphotericin B-susceptible and -resistant Aspergillus fumigatus in a murine model of invasive aspergillosisCoccidioides posadasii contains a single 1,3-beta-glucan synthase gene that appears to be essential for growthEvaluation of endpoints for antifungal susceptibility determinations with LY303366.Photoaffinity analog of the semisynthetic echinocandin LY303366: identification of echinocandin targets in Candida albicansInfluence of test conditions on antifungal time-kill curve results: proposal for standardized methods.Susceptibilities of Candida species isolated from the lower gastrointestinal tracts of high-risk patients to the new semisynthetic echinocandin LY303366 and other antifungal agents.Antifungal activity of LY303366, a novel echinocandin B, in experimental disseminated candidiasis in rabbits.Dosage-dependent antifungal efficacy of V-echinocandin (LY303366) against experimental fluconazole-resistant oropharyngeal and esophageal candidiasis.In vivo pharmacodynamics of HMR 3270, a glucan synthase inhibitor, in a murine candidiasis model.In vitro activity of anidulafungin against selected clinically important mold isolatesLY303366 exhibits rapid and potent fungicidal activity in flow cytometric assays of yeast viability.A glucan synthase FKS1 homolog in cryptococcus neoformans is single copy and encodes an essential function.
P2860
Q24537282-AF033041-8F32-4734-9CDE-F5B446C618B0Q24538858-61774423-22FE-478B-999E-8CC572B8787BQ27025299-483BAF0F-3391-46E7-9718-9613FADCE82EQ28344147-C72C0C81-CD24-47C5-8C49-315C91869669Q28344293-08C6BF5C-160A-432F-B126-A7BB38FF1295Q28345261-566AD7CC-EB79-4C2A-8492-51F6B2B36F3EQ28368930-8E063851-F3B8-40AC-8406-C10FBF0FB937Q28369044-96A4B8C5-C19D-4D06-8548-B0811F1EEFFAQ28369150-08B5E45A-9B07-46DF-995B-C6FE3E38AABAQ28369443-A70475A2-E30B-40F4-AA2A-5060F5877427Q28379123-805A1A67-3B48-430A-B128-2996776E9F3FQ28379470-BA0C2EDB-7219-4FEC-B20B-90E5D628BE01Q33210749-DB91173C-BDE2-46B9-839D-BCDF35D0BCCBQ33693384-4048F0F9-5F0A-47ED-9F0A-58C491DCDE9EQ33695613-8E3F3C9B-8E2F-4784-ACE3-DB2C551D03D1Q33695704-397B0D23-2822-4F6B-A6FB-95282A577E50Q33697398-6A66D6E8-92EA-4615-BADB-C4E28751F9FDQ33977578-2563F30E-4BA0-4BA2-8DD8-B9DE75B3912AQ33981387-CDCB682F-7161-455B-963A-630D23E56F5FQ34881309-4652C58E-58A3-41AB-8940-1EA27A715814Q37734590-E25063BC-5F81-4CB2-BD2B-BBB382909A92Q39470510-80C3E14C-145B-489F-B0BB-FEA9E12CFBF3Q39493735-FC4C6A9E-E3CE-40AF-9D19-FECDFA42998D
P2860
In vitro susceptibilities of clinical yeast isolates to a new echinocandin derivative, LY303366, and other antifungal agents.
description
1997 nî lūn-bûn
@nan
1997 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
In vitro susceptibilities of c ...... , and other antifungal agents.
@ast
In vitro susceptibilities of c ...... , and other antifungal agents.
@en
type
label
In vitro susceptibilities of c ...... , and other antifungal agents.
@ast
In vitro susceptibilities of c ...... , and other antifungal agents.
@en
prefLabel
In vitro susceptibilities of c ...... , and other antifungal agents.
@ast
In vitro susceptibilities of c ...... , and other antifungal agents.
@en
P2093
P2860
P356
P1476
In vitro susceptibilities of c ...... 6, and other antifungal agents
@en
P2093
M A Pfaller
S A Messer
P2860
P304
P356
10.1128/AAC.41.4.763
P407
P577
1997-04-01T00:00:00Z